Detalhe da pesquisa
1.
Adenovirus-Mediated Inducible Expression of a PD-L1 Blocking Antibody in Combination with Macrophage Depletion Improves Survival in a Mouse Model of Peritoneal Carcinomatosis.
Int J Mol Sci
; 22(8)2021 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33920699
2.
Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses.
Mol Ther
; 27(11): 1892-1905, 2019 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31563534
3.
Capsid-deficient alphaviruses generate propagative infectious microvesicles at the plasma membrane.
Cell Mol Life Sci
; 73(20): 3897-916, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27117550
4.
Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses.
Cancer Lett
; 561: 216139, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001752
5.
Optimization of a GDNF production method based on Semliki Forest virus vector.
Eur J Pharm Sci
; 159: 105726, 2021 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33482318
6.
Idiotype vaccines produced with a non-cytopathic alphavirus self-amplifying RNA vector induce antitumor responses in a murine model of B-cell lymphoma.
Sci Rep
; 11(1): 21427, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34728659
7.
A new generation of vaccines based on alphavirus self-amplifying RNA.
Curr Opin Virol
; 44: 145-153, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32898764
8.
Long-Term Systemic Expression of a Novel PD-1 Blocking Nanobody from an AAV Vector Provides Antitumor Activity without Toxicity.
Biomedicines
; 8(12)2020 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33276580
9.
Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T-cell Cross-Priming.
Cancer Res
; 78(23): 6643-6654, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30297531
10.
Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12.
Immunotherapy
; 8(2): 179-98, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26786809